RSS

Reece Armstrong

Reece Armstrong RLS

Reece Armstrong is Editor of European Pharmaceutical Manufacturer.

He can be contacted at reece.armstrong@rapidnews.com

EPM editor Reece Armstrong caught up with Frederique Bordes-Picard, business development for innovative products capsule delivery solutions at Lonza to learn more about the company's new dry-powder inhalation capsule. Read more

Opinion

Reece Armstrong examines the story behind a Cambridge-based biotech’s potential treatment for diabetes. Read more

News

European Pharmaceutical Manufacturer editor Reece Armstrong examines both sides of the argument relating to the world's most expensive drug. Read more

Opinion

European Pharmaceutical Manufacturer editor Reece Armstrong finds out how a new packaging plan from Merck is challenging sustainability in pharma. Read more

Opinion

EPM editor Reece Armstrong sits down with Andrew Bulpin - head of process solutions at the life science business of Merck - to discuss the industry and the company’s new platform for ‘contiGuous’ manufacturing in bioprocessing. Read more

Opinion

EPM editor Reece Armstrong writes why international efforts are essential for global health concerns like AMR and vaccination. Read more

Opinion

A new wearable could mark the future for clinical trials through the better use of real-world evidence to support the approval of new therapies. Read more

News

At this year's Pharmapack, Reece Armstrong caught up with event director Silvia Forroova to discuss why the show has grown so much and what to expect from the industry in 2019. Read more

Opinion

Reece Armstrong sits down with Dr Paul Peter Tak, venture partner at Flagship Pioneering and the former senior vice president of R&D, development leader and chief immunology officer at GSK to gain a global perspective on Brexit and pharma. Read more

Opinion

Reece Armstrong examines Scott Gottlieb's legacy on the FDA and what it means for pharmaceutical manufacturers. Read more

Latest Issue

Antimicrobial resistance (AMR) is one of the biggest threats facing the world but arguably not enough is being done by both pharma companies and governments around the world. Read more

Opinion

Reece Armstrong examines the looming possibility of a 'no deal' Brexit and why the industry is entering the golden age of innovation. Read more

Opinion

EPM editor Reece Armstrong examines the impact a no-deal Brexit would place on medicines supply in the UK. Read more

Opinion

With the potential of antimicrobial resistance (AMR) taking our modern medicine practices back to the stone age, governments around the world need to face the threat head on. Read more

Opinion

In his first Editor's Desk focus, Reece Armstrong asks whether it's time pharmaceutical manufacturers change their approaches to the way drugs are developed, in response to changing healthcare needs around the world. Read more

Latest Issue

Medical device maker, Phillips-Medisize has released a connected health platform to help improve the way people take medication when using connected health devices. Read more

Technology

Digital Innovations Hubs are to be created in the UK to help connect data and fast-track treatments for a range of important diseases like cancer, heart disease and asthma. Read more

News

In the last of a series of articles surrounding the Pfizer Healthcare Hub: London, founder and CEO of Illumr, Jason Lee, talks to reporter Reece Armstrong about the use of AI and data within healthcare. Read more

News

In the second of a series of articles surrounding the Pfizer Healthcare Hub: London, Medopad’s Alex Gilbert, Partnerships, sits down with Digital Health Age reporter Reece Armstrong to discuss how remote patient monitoring is impacting patient care. Read more

News

Manager for the Pfizer Healthcare Hub: London, Dr Hamish Graham, talks to reporter Reece Armstrong about how the Hub is helping healthtech start-ups across the UK and why digital innovation is vital to the NHS. Read more

News